The type I interferon system in systemic lupus erythematosus - PubMed (original) (raw)

Review

doi: 10.1002/art.21571.

Affiliations

• PMID: 16447217
• DOI: 10.1002/art.21571

Free article

Review

The type I interferon system in systemic lupus erythematosus

Lars Rönnblom et al. Arthritis Rheum. 2006 Feb.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
  Banchereau J, Pascual V. Banchereau J, et al. Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010. Immunity. 2006. PMID: 16979570 Review.
• A compass that points to lupus: genetic studies on type I interferon pathway.
  Kyogoku C, Tsuchiya N. Kyogoku C, et al. Genes Immun. 2007 Sep;8(6):445-55. doi: 10.1038/sj.gene.6364409. Epub 2007 Jun 21. Genes Immun. 2007. PMID: 17581625 Review.
• Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
  Wenzel J, Zahn S, Bieber T, Tüting T. Wenzel J, et al. Arch Dermatol Res. 2009 Jan;301(1):83-6. doi: 10.1007/s00403-008-0892-8. Epub 2008 Sep 11. Arch Dermatol Res. 2009. PMID: 18784932 Review.
• Type I interferon and lupus.
  Rönnblom L, Alm GV, Eloranta ML. Rönnblom L, et al. Curr Opin Rheumatol. 2009 Sep;21(5):471-7. doi: 10.1097/BOR.0b013e32832e089e. Curr Opin Rheumatol. 2009. PMID: 19525849 Review.
• Targeting of type I interferon in systemic autoimmune diseases.
  Crow MK, Olferiev M, Kirou KA. Crow MK, et al. Transl Res. 2015 Feb;165(2):296-305. doi: 10.1016/j.trsl.2014.10.005. Epub 2014 Oct 16. Transl Res. 2015. PMID: 25468480 Free PMC article. Review.

Cited by

• Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity.
  Kamen DL, Tangpricha V. Kamen DL, et al. J Mol Med (Berl). 2010 May;88(5):441-50. doi: 10.1007/s00109-010-0590-9. Epub 2010 Feb 1. J Mol Med (Berl). 2010. PMID: 20119827 Free PMC article. Review.
• Current status and challenges of cytokine pharmacology.
  Zídek Z, Anzenbacher P, Kmonícková E. Zídek Z, et al. Br J Pharmacol. 2009 Jun;157(3):342-61. doi: 10.1111/j.1476-5381.2009.00206.x. Epub 2009 Apr 3. Br J Pharmacol. 2009. PMID: 19371342 Free PMC article. Review.
• Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.
  Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB. Kariuki SN, et al. J Immunol. 2009 Jan 1;182(1):34-8. doi: 10.4049/jimmunol.182.1.34. J Immunol. 2009. PMID: 19109131 Free PMC article.
• Recent advances in the genetics of autoimmune disease.
  Gregersen PK, Olsson LM. Gregersen PK, et al. Annu Rev Immunol. 2009;27:363-91. doi: 10.1146/annurev.immunol.021908.132653. Annu Rev Immunol. 2009. PMID: 19302045 Free PMC article. Review.
• [Systemic lupus erythematosus. Target criteria for treatment].
  Alexander T, Biesen R, Jacobi A, Hoyer B, Bruns A, Hiepe F. Alexander T, et al. Z Rheumatol. 2009 Feb;68(1):23-9. doi: 10.1007/s00393-008-0359-5. Z Rheumatol. 2009. PMID: 19145446 Review. German.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information